
PMC:7545501 / 30824-32034
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T29 | 36-44 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T30 | 252-260 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T31 | 652-668 | Disease | denotes | zoonotic disease | http://purl.obolibrary.org/obo/MONDO_0025481 |
T32 | 1114-1122 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T99 | 261-264 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T100 | 389-390 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T101 | 698-705 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
T102 | 731-735 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
T103 | 960-970 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activities |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T22 | 761-775 | Chemical | denotes | pharmaceutical | http://purl.obolibrary.org/obo/CHEBI_52217 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T136 | 0-145 | Sentence | denotes | In light of the faults laid bare by COVID-19, we have already begun reexamining indicators of leadership, trust in government and political risk. |
T137 | 146-406 | Sentence | denotes | The next iteration of the GHS Index, slated to release in 2021, will also emphasise other indicators that COVID-19 has shown to be vital for pandemic response, particularly those capturing state capacity to sustain societal functioning during a major outbreak. |
T138 | 407-552 | Sentence | denotes | At present, we tentatively anticipate adding metrics of government effectiveness, as well as measures examining contact tracing and data sharing. |
T139 | 553-1088 | Sentence | denotes | We also anticipate revising several existing questions and adding over 20 new questions addressing zoonotic disease spillover events, scaling of testing capacities, abilities to test for novel pathogens, non-pharmaceutical interventions, private sector participation in exercises, risk communication, mis-information and disinformation, trade and travel, health security financing, social cohesion, illicit activities carried out by non-state actors, supply chains for medical supplies, laboratory supplies and medical countermeasures. |
T140 | 1089-1210 | Sentence | denotes | Drawing further from the COVID-19 experience, we may also revisit weighting schemes for select categories and indicators. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
102 | 36-44 | Disease | denotes | COVID-19 | MESH:C000657245 |
103 | 252-260 | Disease | denotes | COVID-19 | MESH:C000657245 |
104 | 652-668 | Disease | denotes | zoonotic disease | MESH:D015047 |
105 | 1114-1122 | Disease | denotes | COVID-19 | MESH:C000657245 |